Theratechnologies Inc. (TH.TO)
CAD 2.18
(0.46%)
CAD 2.18
(0.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 51.26 Million USD | 3445.02% |
| 2022 | 1.44 Million USD | -97.43% |
| 2021 | 56.28 Million USD | 2.41% |
| 2020 | 54.95 Million USD | 8.31% |
| 2019 | 50.74 Million USD | 2.93% |
| 2018 | 49.29 Million USD | 985.06% |
| 2017 | 4.54 Million USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 12.5 Million USD | -7.16% |
| 2014 | 13.47 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 65.1 Thousand USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 1.26 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 36.24 Million USD | -11.77% |
| 2024 Q1 | 46.35 Million USD | -9.46% |
| 2024 Q2 | 41.42 Million USD | -10.49% |
| 2023 Q1 | 38.54 Million USD | 2565.7% |
| 2023 FY | 51.26 Million USD | 3445.02% |
| 2023 Q4 | 51.26 Million USD | 7394.3% |
| 2023 Q3 | 684 Thousand USD | -98.24% |
| 2023 Q2 | 38.9 Million USD | 0.92% |
| 2022 Q4 | 1.44 Million USD | -96.32% |
| 2022 FY | 1.44 Million USD | -97.43% |
| 2022 Q3 | 39.32 Million USD | -30.98% |
| 2022 Q2 | 56.97 Million USD | 0.6% |
| 2022 Q1 | 56.63 Million USD | 0.62% |
| 2021 Q3 | 55.98 Million USD | 0.44% |
| 2021 Q2 | 55.73 Million USD | 0.76% |
| 2021 FY | 56.28 Million USD | 2.41% |
| 2021 Q4 | 56.28 Million USD | 0.53% |
| 2021 Q1 | 55.31 Million USD | 0.65% |
| 2020 Q1 | 53.86 Million USD | 6.15% |
| 2020 Q4 | 54.95 Million USD | 0.6% |
| 2020 Q3 | 54.63 Million USD | 0.88% |
| 2020 Q2 | 54.15 Million USD | 0.54% |
| 2020 FY | 54.95 Million USD | 8.31% |
| 2019 Q1 | 49.59 Million USD | 0.6% |
| 2019 FY | 50.74 Million USD | 2.93% |
| 2019 Q2 | 49.96 Million USD | 0.76% |
| 2019 Q4 | 50.74 Million USD | 0.78% |
| 2019 Q3 | 50.34 Million USD | 0.76% |
| 2018 Q4 | 49.29 Million USD | 0.38% |
| 2018 FY | 49.29 Million USD | 985.06% |
| 2018 Q3 | 49.1 Million USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2017 FY | 4.54 Million USD | 0.0% |
| 2017 Q4 | 4.54 Million USD | 3.23% |
| 2017 Q3 | 4.4 Million USD | 0.0% |
| 2017 Q1 | 8.8 Million USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 FY | - USD | -100.0% |
| 2016 Q1 | 12.67 Million USD | 1.34% |
| 2016 Q2 | 8.69 Million USD | -31.42% |
| 2016 Q4 | - USD | 0.0% |
| 2015 FY | 12.5 Million USD | -7.16% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q4 | 12.5 Million USD | 0.0% |
| 2015 Q2 | 11.64 Million USD | -26.38% |
| 2015 Q1 | 15.82 Million CAD | 17.45% |
| 2014 FY | 13.47 Million USD | 0.0% |
| 2014 Q4 | 13.47 Million USD | 5.21% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | 12.8 Million USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 Q1 | - CAD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2000 Q1 | - CAD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - CAD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | -100.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1998 Q3 | 63.27 Thousand USD | -7.83% |
| 1998 Q2 | 68.65 Thousand USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 65.1 Thousand USD | 2.89% |
| 1998 FY | 65.1 Thousand USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 FY | 1.26 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 47.57 Million CAD | -7.75% |
| Avicanna Inc. | 95.36 Thousand CAD | -53654.116% |
| Avant Brands Inc. | 1.74 Million CAD | -2844.342% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -32234.797% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | -6189.693% |
| Knight Therapeutics Inc. | 44.01 Million CAD | -16.46% |
| MediPharm Labs Corp. | 69 Thousand CAD | -74191.304% |
| OrganiGram Holdings Inc. | 79 Thousand CAD | -64787.342% |
| Canopy Growth Corporation | 493.29 Million CAD | 89.608% |
| Willow Biosciences Inc. | 594 Thousand CAD | -8529.798% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | 37.013% |